Media Coverage

Dr. Brian Dontchos shared his thoughts on people living with cancer: “Many people die with unknown cancers that never cause any issues for them.” 

Dr. Nancy Davidson will receive the David Karnofsky Science of Oncology Award for her contributions to breast cancer, which have “spanned preclinical studies of the role of epigenetic changes in breast cancer to phase III clinical trials.”

Dr. Marian Neuhouser explained how previous nutrition guidelines emphasized different types of diets, “which is important so people with different cultural preferences could achieve a healthy diet.”  

Dr. Tom Purcell emphasized federal funding is essential to advancing cancer treatments: “I continue to believe that we have to invest in cancer research in a way that will provide innovative trials and research in the lab and into the clinic.”

Dr. Joe Unger commented on his recent study: “Fatigue might be a marker for things that are otherwise making them vulnerable to potential adverse effects of treatment. It’s important that we listen to what they’re saying.”

Dr. Cyrus Ghajar predicted how to better identify dormant cancer cells: “We’re going to have to go beyond a definition based on unifying features, and instead map the mutations in these cells to mutations in the originating tumor.”

Dr. Larry Corey emphasized that “Thanks to broad U.S. investment, HIV research has opened the door to breakthroughs and treatments for diseases far beyond HIV/AIDS.”

Dr. Rahul Banerjee described a “functional cure” for multiple myeloma: “The myeloma is there. It's not gone. It's just there in a quiet state. But they're probably going to live their whole life without needing a treatment change for myeloma."

Dr. Joe Unger and coauthors commented that better assessing fatigue when people are diagnosed with cancer “could aid in risk mitigation strategies and treatment decision-making.”

Drs. Fred Appelbaum and Irv Bernstein described their early clinical research with a drug for leukemia, with Appelbaum saying: “We kept arguing that this was a novel approach, [that] this would be a sort of paradigm-shifting experiment.”

A study coauthored by Drs. Joe Unger and Salene Jones noted that “in this era of precision medicine, patient-reported fatigue may be an important component of determining risk of toxic effects.”

Dr. Marian Neuhouser discussed her research on eating frequency, highlighting the finding that “People who had the larger meals tended to stay more satiated and for a longer period of time, whereas it was a blunted response for people who had the smaller meals.”

Dr. Jen Specht discussed the importance of the study results: “These results really help us and help a good population of patients who at current have often been left out of large clinical trials where we're investigating novel agents.”

Dr. Heidi Gray shared her thoughts on a new at-home HPV test: “I think it's actually been very well received by most clinicians because they do recognize that a lot of individuals have barriers.”

Drs. Trevor Bedford and Jesse Bloom discussed the flu season, which will likely be dominated by a new version of the virus called H3N2. Bloom said: "Current indicators are that it may be substantially more severe than the typical winter flu season.”

Dr. Mazyar Shadman highlighted the problem of access to CAR-T and how many people who are eligible for it are not actually getting it: “You have a treatment that’s lifesaving, yet we are looking at best 20 percent utilization in the country."

Dr. Joe Unger discussed the issue of a growing proportion of cancer clinical trials funded by industry compared to those funded federally: “A lot of questions that would be of interest to patients may be going unanswered.”

Dr. Chris Su explained his study presented at ASH on the financial stress of cancer: “A lot of times, I think the true toll of a delayed period to treatment is actually the stress of thinking that we’re not getting the cancer treated right away.”    

Connie Carlson, a patient at Fred Hutch, explained her treatment experience and how she’s now: "doing the best work in my life right now. It means a lot to me." 

Dr. Bill Grady shared that in early onset colorectal cancer: “epigenetic age is... higher than people who have late onset colorectal cancer. It suggests that something's causing an accelerated biological aging in those younger individuals.”

Dr. Emily Liang explained a study she presented on treating side effects of CAR T-cell therapy: “We are really trying to move from a reactive management approach of these side effects to a more proactive precision guided and personalized approach.”  

Drs. Lillian Cohn and Dan Reeves shared insights from two groundbreaking HIV studies published on World AIDS Day. Cohn noted: “We’re in a very paradoxical moment in the world. The science is at the best point it’s ever been.”

Dr. Filippo Milano shared progress in using cord blood for transplants: “We don’t just want to cure patients of their blood cancers. We want them to have a high quality of life after their transplant.”

Drs. Fred Appelbaum and Salene Jones reflected on Fred Hutch’s legacy and future. Appelbaum noted that “Interns, residents, and fellows from the university rotated through [Fred Hutch], so there was always a close collaboration.”

Dr. Marian Neuhouser spoke about the study findings, “there is not enough evidence to suggest that you should avoid the foods completely. In fact, some ultraprocessed foods can provide nutrients associated with a lower risk of colorectal cancer.”

Dr. Larry Fong  talked about the challenges of using immune cells to target solid tumors, "When we think about solid tumors, they are primarily in epithelial locations, where immune cells cannot traffic as easily."

Dr. Josh Veatch discussed a study showing how checkpoint inhibitors for cancer worked better for patients who also received COVID vaccines: "It implies that there might be a more general aspect to the vaccine that can be helpful in cancer treatment.”

Dr. Rahul Banerjee explained what “functional cure” means for people with multiple myeloma: “You may still have some abnormalities in the blood work. But they're probably going to live their whole life without needing a treatment change for myeloma.”

Dr. Chris Li hosted a podcast episode with Dr. Bill Grady, who discussed new forms of colorectal cancer screening and noted that “not as many people as recommended participate in screening.”

Drs. Anne McTiernan and Marian Neuhouser discussed increasing rates of cancer in the Midwest. Neuhouser said, “Everyone would like to be able to narrow down cancer risk…but cancer is so complex that it’s usually several factors working together.”

Dr. Phil Greenberg explained how the immune cells called macrophages could be used in cancer immunotherapies, summarizing the growing interest in this strategy: “There’s lots to be done here, and I think we are at the tip of the iceberg.”   

Dr. Joe Unger pointed out that “sustained or increased funding is essential to maintain progress in these areas and to maintain a healthy cancer research ecosystem that balances federally sponsored and industry-sponsored trials.”

Dr. Natasha Kwendakwema shared why it’s important to discuss treatment timelines: “Breast cancer treatment and follow-up often continue for months and years…so understanding the expected timelines can help with planning and peace of mind.”

In partnership with Puget Sound Energy, Fred Hutch installed a heat chiller recovery system. This project resulted in a large grant for the effort.   

Dr. Rachel Issaka summarized results of a recent study: “a rideshare intervention is cost-saving because it allows detection of cancer precursors or cancer at its earliest stage when treatment is cheaper than it would be for advanced stage cancer.”

Dr. Holly Harris discussed the connection between diet and breast cancer risk, including the role of hormones. She said, “...In premenopausal people, diets are not modulating our hormones to any meaningful degree. The ovaries are in charge.”

Omer Awan discussed how health-care systems are handling rapid changes in IT: "cancer centers are now often leading the charge — because the stakes are so high, the data is so rich, and the potential to improve lives is so tangible.” 

Dr. Meghan Koch explained the impacts of breast milk on a newborn’s immunity: “Milk has factors that help shape an infants’ immune response to the microbiota.” 

Dr. Bill Grady noted that colonoscopy remains “the most sensitive and the most specific from a technical standpoint for detecting the premalignant lesions…as well as for detecting colorectal cancer at any stage.”

Dr. Jeff Leek described how a new AI platform developed by the Cancer AI Alliance (CAIA) aims to “put tools in the hands of physicians that enable them to ask questions in plain language and then calculate that across a million patients.” 

Dr. Jen Specht explained the connection between estrogen and cancer: “Estrogen is the female hormone that makes us women, but it’s also a growth factor that can help breast cancer cells grow.”

Dr. Jeff Leek, who helped spearhead the Cancer AI Alliance and is a TIME100 AI honoree, said: “We wanted to be able to build AI for the future while protecting patient privacy and data security.”

Dr. Tom Lynch noted: “Seattle is a center of innovation. And if you look at the growth of Microsoft and Amazon and Starbucks and Costco, it’s not crazy to think that that same cauldron of innovation would have launched the Fred Hutch.”

Of his recognition on TIME’s list of top AI influencers, Dr. Jeff Leek, on behalf of the Cancer AI Alliance, remarked: “We're all trying to accomplish the same goal, which is to help patients get better, live longer, and detect cancer earlier.”

Dr. Larry Fong explained new funding in light of federal cuts to medical research: "It enables us to continue to innovate and move forward instead of throttling back.” Other coverage in GeekWire and Endpoints also covered the funding news.

To demonstrate the connection between nutrition and health, Dr. Neel Dey shared a list of his daily meals. Examples included a breakfast “Egg sandwich and coffee” and a dinner “Veggie fried rice and mango.”

Dr. Joe Unger noted that “decentralized approaches really are about making trial participation easier” for cancer patients.

Dr. Stan Riddell described a study using AI to develop cell therapies as “an exciting advance” and said such models are “likely to generate a whole new class of therapeutics for a variety of diseases that will go beyond cancer.”

Dr. Savannah Partridge spoke about access to breast MRIs: “We’re hoping to be able to offer breast MRI to more women than we do nowadays because it is a really sensitive breast screening tool.”

Dr. Aaron Ring explained how his new Nature study revealed that “autoantibodies that existed in patients before they got therapy could profoundly alter the effectiveness of immunotherapy.” KUOW and HealthDay also covered the study.

Dr. Scott Ramsey discussed the Vanguard study, which aims to understand multi-cancer blood tests: “The bottom line is we don’t know ... when taking one of these tests will give you an opportunity to live longer without cancer — or longer overall.”

Dr. Shailender Bhatia discussed the importance of a new study on melanoma treatments: “The results of this treatment in melanoma are likely to lead to similar success in other cancers.”

Dr. Neelendu Dey shared tips for preventing colon cancer, including diet, exercise and getting screened. He said: "The microbiome, I believe, is a long-term player in improving our health."

The Cancer Letter covered the appointment of Seattle leaders Ric Anderson and Eduardo Peñalver to chair and vice chair of the Board of Directors, as well as Jim Lico joining the board as a new member. 

Dr. Trevor Bedford explained aspects of a new COVID variant: “There's going to be some correlation between the new variants and worse infections, but it's probably not the case that it's due to some intrinsic biological difference.”

Dr. Britney Barber discussed jaw cancer risk factors: “Tobacco and alcohol use are both well-established risk factors. Together, they’re a dangerous combination, boosting your risk at least 15 times above normal.”

Dr. Steve Pergam noted that federal advisory committees that evaluate vaccines “are the envy of most countries in how we address these policies and how we’ve done this. These are people that have spent their lives working on vaccines.”

Dr. Hans-Peter Kiem described his research on gene therapies: “That gets me up every morning, to be honest, to be able to think about how can we really manufacture these treatments to help patients whether it's genetic diseases or cancer.”

Dr. Stacey Cohen discussed tumor DNA tests: “Research is trying to keep up with the pace of clinical use. It’s a really exciting technology, but it’s difficult to interpret and actually use [the] test result.”

Dr. Heather Greenlee discussed a new study on anti-inflammatory diets and colorectal cancer. She said, “The issue that a lot of patients face is that people don’t know how to make these dietary changes that are sustainable over time.”

Dr. Jim Kublin explained that approaches using the mRNA platform for developing an HIV vaccine “are not at all dead in the water” despite mild side effects observed in a recent study.

Dr. Holly Janes pointed out that a new proposal for evaluating updated COVID vaccines is “unclear as to how and whether that trial would be feasible to conduct on the timescale that would be needed.”

Dr. Pete Nelson explained a possible therapy option: “...patients like Biden have a more than 90% chance of responding to therapies that lower testosterone...” Similar coverage ran in The Washington Post, Scientific American and KIRO-TV.

Dr. Dan Lin shared his thoughts on how advances in prostate cancer treatment have changed patient outcomes, saying “Life is measured in years now, not months.”

Dr. Dan Lin discussed Biden’s prostate cancer prognosis, “...he has years to live with this diagnosis. We don’t see anything that’s been released that suggests there’s impending doom..." Dr. Evan Yu was also interviewed. Similar coverage ran on Q13.

Dr. Josh Hill discussed how “immune compromised patients are those that we need to study the most carefully, because they are sometimes at the most risk for the infection or worse outcomes from infectious diseases."

Dr. Barbara Goff explained advantages of the new at-home cancer screening device: “It expands cervical cancer screening to more women, which is good. And it makes [screening] more comfortable, which is also good.”

Dr. Stacey Cohen provided context around a new study: “...as we move to an age where nonoperative management could be a new standard of care with durable and effective treatments, that’s very exciting for patients and providers alike.”

On behalf of the Cancer AI Alliance, Brian Bot accepted GeekWire’s Health Innovation of the Year award, saying it “speaks to the value of this community and how we can work together to solve really difficult problems."

Dr. Tom Lynch discussed the state of cancer research saying, “We are in a period of remarkable progress in cancer research and care, with the pace of new technologies and treatments accelerating rapidly.”

Kristi Stiffler, vice president of clinical research, shared practical advice for those looking into clinical trials: “Start with a conversation with your provider, your doctor can help you understand the types of trials for which you’d be eligible.”

Dr. Neel Dey provided context around gut microbiome research. He said: “When you try to take out, or introduce a species, it can have effects that you didn't anticipate, so this all needs to be done very thoughtfully.”

Dr. Denise Galloway explained the longevity of immune response from her HPV vaccine dose studies: “And so certainly for the 3 to 10 year range, we can say that these memory cells persist, which is a good thing.”

Dr. Filippo Milano commented on the newly announced endowment for cord blood research at Fred Hutch: “This money will allow me to do what I think is very critical — enhancing our personalized medicine.”

Dr. Phuong Vo explained clinical findings that could expand transplant access for people without a fully matched unrelated donor: “The patients experienced low incidence of GVHD, with no instances of severe chronic GVHD reported.”

Dr. Rachel Issaka and Fred Hutch patient Natalie Phelps discussed early onset colorectal cancer. Issaka said, “The number of people diagnosed in 1994 compared to 2024 has now doubled.” 

Dr. Masumi Ueda Oshima explained a clinical trial at Fred Hutch to prevent chronic GVHD. She said, “We think this regimen deserves further study in a multicenter fashion, and we are exploring some potential opportunities for that.”

Dr. Tom Lynch discussed how federal funding impacts cancer research: “Cancer research is done with federal funding, which is why the potential reduction in federal funding for science is so incredibly threatening to science throughout the country.”

Dr. Jesse Bloom commented on how rapidly SARS-CoV-2, the virus that causes COVID, evolves: "The speed at which it's undergone that evolution and the ability it's shown to undergo these big evolutionary jumps is really remarkable."

Dr. Tina Termini explained how her NIH-funded research helps people: "We are searching for better treatments for patients who have already succumbed to cancer who are already suffering from cancer.”

In a profile of Dr. Melody Campbell, she described her structural biology work as fun: “It’s always really rewarding to get a structure where you can see exactly where molecules are in relation to each other.”

In a Q&A, Dr. Thomas Lynch addressed oncology workforce changes: “Yes, it's got high pressure, it's got the same kind of burnout issues that so much of society has now. But oncology is special, particularly because of how the profession evolves.”

Fred Hutch patient Kaelyn Lukson spoke to the importance of biomarker testing to guide treatment: “If I had not received the test and been able to go on this treatment, I literally might not even be here.”

Dr. Steven Henikoff discussed his study published in Science, which showed how histone gene activity “could serve as a biomarker for tumor aggressiveness, complementing traditional histological assessments and improving cancer diagnosis.”

Dr. Anne McTiernan discussed the cancer risk associated with alcohol. She said, “There are several cancers that have increased risk for people that drink alcohol, including what used to be considered very small amounts of alcohol.”

Dr. Joe Unger reflected on how changes to clinical trials during the COVID pandemic “forced the sudden adoption of all of these procedures and, in my view, I think that their adoption is going to have a net positive impact on the entire system.”

Dr. Joe Unger reflected on how changes to clinical trials during the COVID pandemic “forced the sudden adoption of all of these procedures and, in my view, I think that their adoption is going to have a net positive impact on the entire system.”

In a story focused on reader questions about cancer, Dr. Kevin Cheung talked about metastasis. He said, “Much about how tumors metastasize — spread and take up residence in faraway sites – still remains a mystery.”

In a story focused on reader questions about cancer, Dr. Kevin Cheung talked about metastasis. He said, “Much about how tumors metastasize — spread and take up residence in faraway sites – still remains a mystery.”

Dr. Megan Shen explained how her research has shown how people at the end of life appreciate simple pleasures. She said, “They finally figured out that the magic is trying to enjoy, right now while you have it, regardless of what that looks like.”

Dr. Megan Shen explained how her research has shown how people at the end of life appreciate simple pleasures. She said, “They finally figured out that the magic is trying to enjoy, right now while you have it, regardless of what that looks like.”

Dr. Rahul Banerjee described his research studies of a commonly used steroid: “We encourage future trials to investigate lowered-dose dexamethasone strategies prospectively, either at treatment onset or within a few cycles of treatment initiation." 

Dr. Paul Buckley spoke about Bridgette Hempstead, a Fred Hutch patient, research collaborator and advocate. He spoke about how Bridgette fought for “and everyone who was underserved. That was her issue. That was her purpose. That was her commitment.”

Dr. Rahul Banerjee described his research studies of a commonly used steroid: “We encourage future trials to investigate lowered-dose dexamethasone strategies prospectively, either at treatment onset or within a few cycles of treatment initiation." 

Dr. Paul Buckley spoke about Bridgette Hempstead, a Fred Hutch patient, research collaborator and advocate. He spoke about how Bridgette fought for “and everyone who was underserved. That was her issue. That was her purpose. That was her commitment.”

Dr. Joe Unger led a study on complications after prostate cancer treatment. He said: “It’s really important for men not just to understand how commonly these complications can occur, but how far out in time they are still meaningful.”

Dr. Joe Unger led a study on complications after prostate cancer treatment. He said: “It’s really important for men not just to understand how commonly these complications can occur, but how far out in time they are still meaningful.”

Dr. Anne McTiernan discussed the impact alcohol can have on cancer risk and why warning labels are helpful. She said, “If you get information out to people, then they can make their own choices about what might be healthier for them.”

Dr. Anne McTiernan discussed the impact alcohol can have on cancer risk and why warning labels are helpful. She said, “If you get information out to people, then they can make their own choices about what might be healthier for them.”

Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”

Dr. Keith Jerome explained how dormant herpes infections can emerge “from this hiding place in the nerves... reactivate themselves and come back out, transmit to a new person or they can cause visible or sometimes painful lesions.”

Dr. Jesse Bloom commented on viral mutations found in a case of H5N1. He said, “It’s caught the attention of a lot of flu virologists, including myself, because some of the sequence has evidence of some of the types of mutations we worry about.”

Dr. Megan Shen described ways people can help loved ones diagnosed with cancer, including checking in and saying: “I'm thinking about you, I'm here to offer support in whatever way you want.”

Dr. Masumi Ueda Oshima discussed her Science Translational Medicine study showing how transplanted blood stem cells continue to form healthy new blood cells “even after many decades of transplanted donor cells making blood cells every day.”

Kelly Nelson spoke about the importance of sexual health support for breast cancer patients: “sexual health is a huge indicator of quality of life and mental and emotional well-being, and should be a priority for every patient.”

Dr. Larry Fong listed examples of new and upcoming cell therapies for solid tumors and described worldwide efforts to develop CAR T cells. He said: “The collective knowledge is growing at an accelerated pace.”

Dr. Christina Termini created an Atlas of Inspiring Hispanic/Latinx Scientists, hosted on Fred Hutch’s website, to connect and raise awareness of scientists from underrepresented groups. She commented: “We’re here and we’re not going anywhere.”

Drs. Ruth Etzioni and Scott Ramsey discussed multi-cancer early detection blood tests. Etzioni noted, “The future of screening is going to look different from the past” although “we’re not quite there.”

Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”

Dr. Lei Deng shared his thoughts on non-small cell lung cancer treatment data: “It is still not strong enough or definitive enough to make it standard of care to use dual checkpoint blockade for [patients with STK11 and/or KEAP1 mutations].”

Dr. Joe Unger pointed out that: “Federally sponsored, cancer clinical research has a unique role in identifying treatments that are best for patients. It’s not a role that can be supplanted by industry.”

Dr. Megan Shen summarized from her research of people facing serious illnesses that what people really want in life is “peace and love.” She added: “These are the only things that seemingly encompass all the other desires we have as humans.”

Dr. Jerry Radich explained his lab’s involvement in a new NCI-led effort to use genomics testing to screen patients. He said, “What we learn from myeloMATCH may have a major impact on the future of clinical trials in leukemia and beyond.”

Dr. Chris Li and peers discussed DEI in the cancer workforce at a recent policy summit. In recruiting a diverse pool of job applicants, Li urged others to “treat search as a verb.”

STAT included Miguel Paredes in the Bedford Lab and Yapeng Su in the Greenberg Lab in its Wunkerkinds awards to 27 of the “most impressive doctors and researchers on the cusp of launching their careers.”

Dr. Danielle Kirkey explained the balance of hope and reality when caring for patients. She said, "Anything we can do to give the best quality of life for as long as possible is always at the forefront of our mind.”

Dr. Brian Dontchos talked about dense breast classification: “Classification can vary depending on the doctor reading the mammogram because it’s somewhat subjective.” The story was syndicated in several news outlets.

Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”

Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”

Dr. Ming Yu explained how aging cells that accumulate in the body can create a “tumor-promoting microenvironment,” but a certain drug may be able to eliminate these “zombie cells” and prevent them from developing into cancer.

Dr. Thomas Lynch discussed the newly formed Cancer AI Alliance: “What was interesting about this whole process was how we were able to bring together these four incredible cancer centers, and these four major tech companies.”

Dr. Jesse Bloom explained how virus mutations could change the accuracy of serology tests for infections: "This type of mutation could make you want to then redo the assays with a virus that contained that mutation.”

Dr. Joe Unger explained the scale of the cancer clinical trial funding gap: “We recognized that industry was playing an increasing role in cancer clinical research compared to decades ago. But we didn't realize the difference was this dramatic.”

Dr. Jesse Fann explained the negative impact of keeping a cancer diagnosis private: “In the long term, holding emotions back without an outlet can lead to an increase in stress, anxiety, depression, [and] social isolation.”

Drs. Denise Galloway and Nina Salama discussed how HPV and H. Pylori can cause cancer. Galloway said, “If you vaccinate someone who’s young, the risk goes down to zero.”

Dr. Megan Shen wrote about how to improve communication about pain between patients and their health care providers: “Addressing this vulnerable group’s pain needs is a critical public health concern.” 

Fred Hutch’s announcement of the acquisition of three buildings in South Lake Union, including the Steam Plant, was featured. It noted the change from building a new facility on campus to instead acquiring the space. 

Dr. Rahul Banerjee explained symptoms of multiple myeloma and treating the disease with CAR-T. He said, “Cancers of the immune system often know all the tricks of the immune system and are able to bypass them. With CAR-T, you level the playing field.”

Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”

Dr. Veena Shankaran highlighted how financial strain impacts patients: “Cancer affects work, income, depletes savings, changes the way you spend your money, contributes to debt, and may affect how you plan financially for your family members.”

Kelly O’Brien was quoted in this story which highlighted the record-breaking Obliteride turnout. She said, “Obliteride brings together a powerful, one-of-a-kind community.”

Dr. Jennifer Adair explained the need for gene therapy clinical trials to include people from different populations around the world. Otherwise, she said: “we’re killing time thinking that we’ve got something that’s going to be a one shot fits all.”

Dr. Bill Grady commented on new tests to detect circulating tumor DNA in blood: “There is a lot of work going on in the field of blood-based cancer screening tests to improve on their current accuracy.

Brian Minalga discussed the lack of health data about trans people: “Even though trans people are participating in clinical research and giving our biospecimens, our blood, our tissues, our time... [those data] don’t make it back to us.”

Dr. Rahul Banerjee recommended that patients ask their oncologists for trusted sources of information. He said, “I think patient support groups for my patients have been tremendously important because they learn from each other.”

Dr. Bill Grady emphasized: “What breaks my heart is that it’s preventable. One of my biggest joys is when I’m doing colonoscopy and I can take out polyps.” Grady was also quoted in stories in Axios, CNN, MedPage Today and VeryWell Health.

Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”

Dr. Lisa Newcomb commented on her recent study of active surveillance for prostate cancer. She said, “These results demonstrate active surveillance as an effective management strategy for patients diagnosed with favorable-risk prostate cancer.”

Dr. Elizabeth Loggers spoke about cancer treatment and fertility: “After you start treatment, you may already have some lasting effects on your fertility. It is important to have that conversation upfront and to act if it is important to you.”

Dr. Lindsay Gunnell explained why skin cancer rates are increasing in Washington: “There's a false sense of security here with our cloud cover that we're getting protection.”

Dr. Kemi Doll discussed the results of her JAMA Oncology study saying, “These findings suggest that the transvaginal ultrasonography triage strategy is not reliable among Black adults at risk for endometrial cancer.” Medscape also covered the study. 

The Cancer Letter highlighted Science Education’s new program, Partners in Science 2.0, along with other summer programs at Fred Hutch that aim to educate students and teachers. 

Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”

Dr. Yaw Nyame encouraged men in their 40s to discuss cancer screening with their doctors. “That routine of going in annually having to check up, discussing preventative health,” he said, “unfortunately, that’s not the norm for a lot of men.”

Dr. Stephanie Lee advocated for having “quality of life” be an endpoint in cancer treatments, along with survival. She said: “It's not just survival. If you look at FDA parlance, it's length of life and it's quality of life.”

Dr. Mazyar Shadman discussed CAR-T vs. standard of care for large B-cell lymphoma patients: “CAR-T remains to be standard of care for patients who are eligible and if they have access to it.” 

Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”

Dr. Sara Hurvitz discussed three breast cancer studies presented at ASCO, “this was an exciting conference, with a large amount of data out.” The three abstracts discussed were  DB-06, postMONARCH and INAVO120 study.

A feature on leaders in cancer clinical trials included Drs. Garnet Anderson, Ruth Etzioni, Ziding Feng, Katherine Guthrie, Charles Kooperberg and Scott Ramsey for their work on the new Cancer Screening Research Network, based at Fred Hutch.

Dr. Chris Li explained: “I felt a responsibility to try and enhance the diversity of our faculty more broadly and provide some of that mentorship and sponsorship that I think could help promote further diversity in science.”

Dr. Elizabeth Loggers discussed the benefits of offering patients palliative care virtually: “They can be at home, in their pajamas, and their caregivers or anyone else across the country can sit in on that appointment to act as support.”

Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”

Dr. Lisa Newcomb discussed active surveillance for prostate cancer in her new study: “We hope that this study encourages the national acceptance of active surveillance instead of immediate treatment for prostate cancer.”

Dr. Pavitra Roychoudhury described how researchers sequenced a bird flu genome from store-bought milk, noting that “this is, to our knowledge, the first time it’s been done in commercially available milk, to obtain the full genome.”

Dr. Scott Ramsey emphasized that cancer patients who file for bankruptcy have an 80% higher risk of dying from cancer than patients who don’t file. He said, “There actually was a pretty big detriment for survival.”

Dr. Trevor Bedford noted that “separate from the sequencing for evolution [of the virus], which I think is very important, just even understanding prevalence through space and time... would be really helpful and important.”

Louis Shackleford emphasized that “the prospect of having a vaccine that can last for years and give us sustained protection from HIV would be an amazing boon for communities such as the Black community who disproportionately are suffering from HIV.”

Dr. Janie Lee discussed how early screening saves lives: “And increasingly now, there's information that screening in the 40s also reduces breast cancer as well."

Dr. Joe Unger and collaborators pointed out that in their study of cancer clinical trial participation, “these results suggest that contributions to clinical research for adults with cancer is more common than is typically realized.”

Dr. Neel Bhatt and co-authors found lower employment rates in adult survivors of childhood cancer, suggesting “a multidisciplinary approach involving survivors, clinicians, and employers” is needed to address their long-term employment needs.

Dr. Jennifer Adair discussed her work with collaborators across the globe and the challenges of gene therapy access. She also said, “I would love to see patients engaged as co-creators in these medicines in much more meaningful ways.”

Dr. Jesse Bloom shared context amidst ongoing concerns about the H5N1 virus: “H5N1 has been circulating in various species and causing sporadic human infections for over two decades, and so far we haven’t had a pandemic.” 

Dr. Janie Lee commented on new breast cancer screening guidelines. She said they would help create “less confusion among women about breast cancer screening” and that “the scientific evidence is clear mammography saves lives.”

In an editorial, Dr. Hans-Peter Kiem praised success in gene therapies and called for more research in in vivo gene therapy to enable expanding “the availability away from specialized centers.”

Dr. Chris Johnston described next steps for work published in Nature with Dr. Susan Bullman: “Because this bacterium is so intimately associated with cancers, it raises the question, ‘can we harness this?’ That’s something we’re very interested in.”

Dr. William Grady explained the limitations of new blood tests for cancer noting they are “not effective for brain cancer because brain cancer spreads rapidly, even when early and very small, so it is not often curable even at an early stage.”

Dr. Ming Yu discussed research of therapies that “cause ‘zombie cells’ to die without harming normal cells” as having potential “not only to help people live longer, but also live healthier and hopefully cancer-free.”

Dr. Joe Unger underscored that “as we work to increase participation in cancer research studies and make them more accessible to patients, we need an inclusive, accurate assessment of current participation to inform these policies.”

Dr. Rahul Banerjee encouraged use of minimal residual disease to guide multiple myeloma treatments. He said, “I would be very excited about trials that use MRD as an endpoint to get more drugs to our patients sooner.” He also spoke with Endpoints.

Dr. Megan Shen shared tips on how parents can support their adult children who are coping with cancer. She emphasized communication, since an “an adult cancer patient’s needs ‘can be wildly different from one child to the next.’”

Natalie Phelps, a patient with colorectal cancer, advocated for lowering the screening age: “lowering the age from 50 to 45 for the start of (having a) colonoscopy is a good step in the right direction. I’d like to see it lowered even more.”

Matthew Triplette discussed trends in people younger than age 50 getting cancer, and how he doubts there’s “some new, very dangerous cancer risk factor out there that’s causing tons of excessive cases in younger folks.”

Fred Hutch’s Hanako Osuga received the GeekWire award for her work with the Coding for Cancer program, which helps students from underrepresented groups in STEM get experience with computing skills in biomedicine.

Dr. Jesse Bloom explained how researchers are studying how coronavirus works as populations have immunity to it. He said, “The virus is still evolving, it’s still infecting large numbers of people. We need to keep tracking this.”

Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.

Dr. Rachel Issaka noted: “If people have more options that are convenient for them, they are more likely to participate in colon cancer screening, and we can pick up earlier cases where treatments are most effective.”

Dr. David Maloney explained the work he did in the 1990s to develop antibodies targeting cancer. He said, “With this approach, it was one antibody that was only good for one patient. You had to make an antibody for essentially every patient.”

Dr. Bill Grady commented on results from a study he led of a new blood test for colorectal cancer, emphasizing that “more screening should result in fewer cancer deaths.” This story ran in local outlets across the U.S.

Dr. Bill Grady explained that colonoscopies and “stool-based tests have that kind of ‘ick’ factor related to them. We need to find tests that people are going to use.”

Denene Prophet-Williams, MBA, MLA, BSN, is featured as Fred Hutch’s newly-named vice president and chief nursing officer. The Cancer Letter and GeekWire also covered the news. 

Dr. Rachel Issaka stressed the importance of prevention and screening: “March is colorectal cancer awareness month, and colon cancer is one of the most common cancers. But we can all do things to reduce our risk.”

Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”

Dr. Yunda Huang discussed HIV vaccines at CROI: “I've been working in this field for 20 years now and there is a misconception that with pre-exposure prophylaxis, our job is done, but HIV is so far  away from being solved.”

Dr. Janice Kim commented on a new study to treat triple-negative breast cancer.

Dr. Christopher Kemp discussed using lab tests of existing drugs on patients’ tumor cells to see which treatment works best.

Dr. Jonathan Bricker shared his motivation to create QuitBot.

Dr. Ruth Etzioni gave context to breast cancer incidence rates.

Dr. Petros Grivas discussed the different bladder cancer types.

Dr. Bill Grady explained why earlier screening is not covered by insurance.

Dr. Jesse Fann shared insight as to why some people choose to keep their cancer diagnosis private.

Dr. Jim Boonyaratanakornkit encouraged people to get vaccinated for COVID, flu and RSV.

Dr. Kleber Fertrin discusses the significance of new treatments.

Dr. Jesse Bloom said it is too early to say whether the latest COVID variant called JN.1 will cause surges of infections.

Dr. Megan Shen listed reasons why the holiday season can trigger grief. 

Dr. Sara Hurvitz received substantial media attention for HER2CLIMB-02 trial results she presented at the San Antonio Breast Cancer Symposium.

Dr. Megan Shen discussed how open conversations can improve how people cope with grief, pain and other challenges.

Dr. Julie Overbaugh commented that “many people probably have very low levels of potential tumor cells in the body that are kept at bay by the immune system.

Dr. Daniel Blanco-Melo was named a Science News “Scientist to Watch.”

Dr. Matty Triplette discussed new expanded guidelines for lung cancer screening.

Dr. Josh Hill pointed out the need for preventive COVID-19 therapies. 

Dr. Nina Salama explained the biology of the bacteria H. pylori.

Dr. David Maloney discussed CAR T-cell therapy for treating CLL.

Dr. Joe Unger found that the Medicaid expansion of the Affordable Care Act enabled many low-income individuals to become eligible for Medicaid.

A news brief covered the Fred Hutch announcement of Dr. Lawrence Fong joining Fred Hutch.

Dr. Jerry Radich described the substantial progress in diagnosing and treating CML.

Dr. Riha Vaidya and collaborators commented on clinical trial access. 

Dr. Larry Corey said we can honor Dr. Stephaun Wallace “not only in developing safe and effective vaccines against HIV and COVID, but in seeing the equitable distribution and accessibility of these vaccines globally. He would expect no less of us.”

Coverage of First Lady Jill Biden's visit to Fred Hutch appeared on the front page. 

A new study led by Dr. Burcu Darst could change gene panel testing.

Hanako Osuga, Coding for Cancer program lead, commented on the importance of the program.

Dr. Phil Greenberg, president of AACR, expressed optimism for some cancers.

In a brief, The Cancer Letter covered the announcement of Fred Hutch’s leadership of a new Asian American, Native Hawaiian and Pacific Islander cohort study.

Dr. Motoko Koyama described her study on the microbiome.

Dr. Joe Unger emphasized that findings from a study.

Dr. Harmit Malik commented on a new study identifying how certain genes that help us survive also can harm us.

Dr. Marianne Dubard-Gault emphasized the importance of health providers providing context to people who get health screenings.

Dr. Amanda Paulovich described her new study to better improve treatment for ovarian tumors.

The Biden administration named Dr. Matthew Triplette a cancer moonshot scholar.

The Science Education Program was featured. 

Dr. Rachel Issaka shared her experience as a clinician.

In a podcast, Dr. Jesse Bloom commented on how he got interested in hte covid pandemic origins. 

Dr. Fred Appelbaum explained how bone marrow transplantation has led to other treatments.

Dr. Yaw Nyame and his patient, Floyd Gossett, spoke about the importance of Black men getting screened for prostate cancer.

Dr. Veena Shankaran discussed financial toxicity.

Dr. Aaron Ring commented on his move to Fred Hutch.

In a podcast and Q&A, Dr. Fred Appelbaum spoke of his newly published book on Dr. Don Thomas’s life and research.

Dr. Rachel Yung commented on new mammogram guidelines. 

Dr. Stacey Cohen commented on a study of an experimental AI tool.

Dr.  Holly Harris commented on her new study looking at ovarian cancer risk. 

Dr. Larry Corey discussed the current approach in HIV vaccine research.

Dr. Jesse Fann discussed the importance of screening for depression among cancer patients.

Dr. Larry Corey discussed HIV vaccine research. 

Dr. Eric Holland discussed a new study to understand side effects of immunotherapies.

Dr. Bill Grady emphasized the importance of colon cancer screening.

Dr. Rachel Issaka pointed out health disparities in colorectal cancer survival.

A story on the opening of the new clinical space at Fred Hutch.

Dr. Christoph Lee commented on the new dense breast disclosure requirements. 

Dr. Megan Shen discussed her work with families making health care decisions.

Dr. Cyrus Ghajar discussed the vision for MET-X.

Dr. Joe Unger explained additional benefits of publicly-funded cancer clinical trials.

Dr. Delphine Chen shared her thoughts on the use of radioligand therapy.

Saiyare Refaei shared details about their partnership with Fred Hutch’s PACD program.

Dr. Shaveta Vinayak commented on progress by Dr. Nora Disis’ team on therapeutic breast cancer vaccines.

Dr. Kristin Anderson explained why mesothelin is a high-priority target for solid tumor cell therapies.

Dr. Jesse Bloom put XBB.1.5  into context with virus evolution.

Dr. Jesse Bloom commented on mutations that make XBB.1.5 different from the omicron variant.

Kathy Surace-Smith was featured among six Seattle philanthropists.

A feature story on COVID-19 variants and implications for vaccines cited a 2021 study led by Dr. Jesse Bloom.

Dr. Molly Tokaz shared additional insights about her research presented at ASH 2022.

Hilary Hehman commented on the program. 

Dr. Ulrike Peters commented on her Nature Genetics paper.

Dr. David Dean commented on issues in oral health, including cavities and dry mouth, following cancer treatment.

Dr. Hong Xiao pointed out that his analysis found health disparities and “trials’ failure to report certain demographics, despite federal requirements.

Dr. Julie McElrath explained the germline targeting vaccine approach.

Dr. Larry Corey underscored that implementation of vaccines is important. 

Dr. Trevor Bedford explained that vaccines and infections from earlier SARS-CoV-2 variants created the initial niche for omicron to spread.

Dr. Steve Pergam gave practical guidance for managing risk of infection as an immunocompromised person.

Dr. Stephaun Wallace explained how lack of data on transgender people living in WA leads to health inequities.

Dr. Mazyar Shadman commented on a clinical trial for a CAR T-cell therapy that was developed at Fred Hutch to target CD20 protein on cancer cells. 

Dr. Alpana Waghmare discussed how existing treatment options are less effective against new COVID variants.

Dr. Anne McTiernan recommended a reasonable approach to limiting ultraprocessed foods.

Dr. Larry Corey urged the development of new COVID drugs and vaccines.

Dr. Alpana Waghmare commented on rising cases of respiratory illness this fall and winter.

Dr. Megan Shen shared tips on avoiding burnout.

Dr. Jesse Bloom commented on how COVID variants could change in the fall and winter.

Dr. Thomas Lynch commented on the Bezos family gift. 

Coverage of the Bezos family gift to Fred Hutchinson Cancer Center. 

Dr. Heather Greenlee discussed new guidelines issued by SIO/ASCO on non-drug cancer pain treatments.

Dr. Janice Kim spoke about radiation therapy for breast cancer and what patients need to know about therapies and effects on the body.

Dr. Trevor Bedford projected that COVID-19 will infect roughly 50% of people in the U.S. each year.

Drs. Michael Emerman and Daniel Blanco-Melo discussed how viruses work their way into genomes and over time no longer infect others.

Dr. Jim Boonyaratanakornkit shared advice for how caregivers can help prevent infection when a loved one is receiving treatment.

Kelly O'Brien commented on what the $78 million gift for precision oncology will mean for Fred Hutch. 

More than more than 80 physicians, physician assistants and nurse practitioners were included in the Seattle Met Magazine’s 2022 Top Doctors list.

Dr. Aakanksha Singhvi discussed the biological changes in the brain during aging, including interactions between types of brain cells.

Dr. Hannah Linden discussed endocrine therapy.

Dr. Larry Corey joined Jake Whittenberg for a bike ride and then sat down to discuss lessons learned during COVID.

Dr. Will Gwin provided commentary about the recently FDA-approved treatment for HER2-Low breast cancer.

Seattle Met recognized bone marrow transplantation advanced by Fred Hutch as one of the top medical innovations developed in the region.

Dr. Holly Harris commented on her study on the link between psoriasis, psoriatic arthritis and endometriosis.

Dr. Nina Salama discussed H. pylori. 

Dr. Trevor Bedford commented that a virus’s ability to mutate around our immune defenses can continue indefinitely.

Highlights from Dr. Anthony Fauci and Dr. Larry Corey’s fireside chat was covered as well as the presentation of the honorary Hutch Award.

The presentation of the honorary Hutch Award to Dr. Anthony Fauci at the Mariners game was covered. 

Arlyce Coumar, an advanced practice nurse at Fred Hutch, commented on the importance of advocacy for oncology nurses. 

Kathryn Kistler of the Bedford lab and Dr. Jesse Bloom discussed how SARS-CoV-2 will keep evolving.

Dr. Stephaun Wallace provided context around rising HIV infections globally.

Dr. Jesse Bloom agreed with F.D.A. recommendations for the COVID vaccine to be updated based on Omicron, despite ongoing evolution of the virus.

Dr. Stephaun Wallace commented on monkeypox risk.

Dr. Gabriela Chiorean described new findings in chemotherapy and radiation regimens for people with advanced pancreatic cancer.

Drs. Jesse Bloom, Trevor Bedford and other experts encourage updating covid vaccines to protect against Omicron subvariants.

Seattle Magazine featured Fred Hutch scientists Drs. Phil Greenberg, Denise Galloway, E. Gabriela Chiorean and Petros Grivas in an article about doctors who continue to make Seattle a hotbed of cancer research and treatment.

Dr. Melody Campbell is listed as one of the 22 Pew scholars.

Dr. Liz Duke explained a study of antivirals to prevent COVID.

Dr. Joe Unger commented on a study he led on treatment-associated adverse events by sex.

Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.

Dr. Josh Veatch discussed a New England Journal of Medicine study about a T cell receptor therapy for pancreatic cancer.

Dr. Jonathan Bricker discussed smoking cessation.

Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.

Dr. Phil Greenberg commented on his recent AACR election.

Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.

Dr. Rachel Bender Ignacio advocated for expanded access to COVID antivirals.

Dr. Joe Unger shared his hopes for the treatment of cancer patients. 

A STAT special report noted Dr. Trevor Bedford’s COVID predictions.

Dr. Heather Greenlee discussed her new study on breast cancer and cardiovascular risk.

Drs. Tom Lynch and Paul Ramsey describe unified adult cancer care.

Dr. Tom Lynch spoke about Fred Hutch’s growing catchment area and how to serve populations across WA state.

Drs. Paul Ramsey and Tom Lynch discuss the cancer care restructure.

Dr. Steven Henikoff discussed new Science papers detailing gaps in the human genome, including on centromeres.

Dr. Bloom and Dr. Starr study virus evolution.

Dr. Veena Shankaran and coauthors urged more support for people with cancer.

Dr. Josh Schiffer reflected on the evolving nature of the pandemic.

Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.

Dr. Joe Unger discussed future research building on a study he led.

Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.

Dr. Elizabeth Halloran shared her thoughts on COVID-19 outlook in the U.S.

Dr. David Maloney commented on a report of long term remissions with CAR T-cell therapy.

Dr. Marie Bleakley discussed her work on naive T cells and graft-vs-host disease.

Drs. Michele Andrasik and Stephaun Wallace discussed diversity in vaccine trials.

Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.

Dr. Elizabeth Duke explained how COVID antivirals work.

Dr. Veena Shankaran shared findings from a recent study.

Dr. Trevor Bedford shared predictions about omicron.

Dr. Trevor Bedford discussed the Seattle Flu Study and tracking viruses in a Bloomberg mini-documentary on genomic surveillance.

Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.

Dr. Jesse Bloom and other experts call for new standards for data transparency.

Travel, language and barriers are all barriers to CAR T treatment, Dr. Anurekha Hall explained from findings she presented at ASH.

Hilary Hehman described the Pacific Northwest’s growing biotech role.

Dr. Sylvia Lee emphasized early detection in the treatment of melanoma.

Dr. Josh Schiffer compared omicron to previous variants.

Dr. Larry Corey highlighted the strain on hospital systems.

Dr. Josh Schiffer characterized recent COVID variants.

Dr. Trevor Bedford shared insights in a Q&A, including updating COVID vaccines to circulating variants.

In a Q&A, Dr. Trevor Bedford discussed the rapid rise of omicron and challenges in detecting cases.

Dr. Trevor Bedford joined a press briefing on omicron. 

Dr. Jennifer Lund explained the immune response to COVID.

Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.

Dr. Trevor Bedford and Andy Slavitt discussed omicron.

Dr. Trevor Bedford predicted a coming wave of omicron infections.

Dr. Andrew Hsieh gave an overview of bladder cancer and what treatments are on the horizon.

Dr. Jesse Bloom and a coauthor answered questions about omicron.

In a profile, Dr. Shivani Srivastava talked about how she first got interested in immunology.

Dr. Josh Schiffer described his concerns about omicron infections.

In an omicron-focused Q&A, Dr. Trevor Bedford mentioned how to prevent future variants.

Dr. Trevor Bedford commented on genomic surveillance of SARS-CoV-2.

Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.

Dr. Elizabeth Halloran talked about implications of the latest COVID-19 variant.

Dr. Trevor Bedford discussed omicron’s evolutionary path.

Dr. Trevor Bedford discussed early reports of spread of the omicron variant. 

Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.

Dr. Trevor Bedford explained how omicron differs from other gradually evolving strains of SARS-CoV-2.

Dr. Trevor Bedford spoke on sequencing of variants. 

Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.

Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.

Kelly O’Brien discussed crypto donations to Fred Hutch, which is limited at this point but an important new way to reach donors.

Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.

Dr. Elizabeth Halloran commented on COVID-19 immunity in the U.S.

Dr. Trevor Bedford’s recent Twitter thread on how SARS-CoV-2 might continue to evolve was featured. 

Dr. Michele Andrasik noted that HVTN and CoVPN’s experience in engaging diverse communities in vaccine studies can support other areas of research.

Kathy Briant and Dr. Rachel Issaka discussed how the pandemic has reduced cancer screenings.

Dr. Tyler Starr received a STAT Wunderkind award for his research on SARS-CoV-2 evolution.

Dr. Ziding Feng discussed the link between diabetes and pancreatic cancer, specifically the need for more testing.

Dr. Larry Corey commented on measures enacted to fight COVID-19. 

Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.

Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine. 

Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.

Rachel Eguia, a research technician in the Bloom Lab, and Katie Kistler, a graduate student in the Bedford Lab, described SARS-CoV-2’s mutations.

Dr. Rachel Bender Ignacio provided perspective on breakthrough COVID infections.

Dr. Trevor Bedford advocated for updating COVID vaccines against the Delta variant. 

Dr. Rachel Issaka was featured as one of PSBJ's 40 under 40. 

Dr. Jesse Bloom explained how SARS-CoV-2 has changed.

Dr. Larry Corey underscored the safety of COVID vaccines.

Dr. Larry Corey commented on COVID vaccine boosters.

Dr. Rachel Bender Ingacio characterized clinical trial results for molnupiravir.

Dr. Marie Bleakley discussed progress in T-cell receptor therapy. 

Dr. Elizabeth Duke explained the potential of molnupiravir.

Dr. Trevor Bedford commented on being named a 2021 MacArthur Fellow.

Dr. Trevor Bedford reflected on receiving recognition for his research on viral evolution.

Dr. Elizabeth Duke spoke about the promise of an oral antiviral to treat and even prevent COVID.

Drs. Erick Matsen and Trevor Bedford were named Howard Hughes Medical Institute investigators.

Dr. Mark Headley discussed his research on how to make single-cell experiments more efficient.

Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:

Hilary Hehman described the entrepreneurial culture at Fred Hutch that has allowed its commercial endeavors to thrive.

Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.

Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.

Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.

Dr. Larry Corey noted that vaccine boosters may prevent transmission.

Dr. Scott Ramsey commented on how the standard treatment for sickle cell disease is more costly than a new curative approach.

Dr. Jesse Bloom talked about the evolution of coronaviruses, including SARS-CoV-2.

Dr. Trevor Bedford characterized the landscape of COVID variants.

Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.     

Dr. Riki Peters and collaborators spoke about new research to understand colorectal cancer disparities in Alaska Native people.     

Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.

A new study from Dr. Stan Riddell’s lab shows how to improve CAR T-cell targeting.

Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.

Dr. Holly Janes spoke with NPR.

Dr. Larry Corey discussed COVID vaccine boosters.

Dr. Larry Corey discussed breakthrough cases of COVID.

Dr. Josh Schiffer discussed the rise of variants.

Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.

Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.

Dr. Tyler Starr discussed his research on SARS-CoV-2 evolution.

Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.

Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.

Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.

Dr. Larry Corey commented on COVID vaccines in immunocompromised people.

Dr. Trevor Bedford commented on the delta variant with The Washington Post.

Allison Greaney, a graduate student in Dr. Jesse Bloom’s lab, discussed her recent study on SARS-CoV-2 immunity.

Dr. Jonathan Bricker shared strategies for quitting smoking.

Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.

Dr. Parth Shah discussed his study on how to encourage HPV vaccination.

Dr. Tom Lynch joined Seattle Cancer Care Alliance, UW Medicine and Seattle Children’s leaders in describing how the new structure will expedite new therapies.

Dr. Tom Lynch described how the restructure of Fred Hutch, UW Medicine, Seattle Children's, and Seattle Cancer Care Alliance could improve startups.

Dr. Jesse Bloom discussed how SARS-CoV-2 will continue to evolve.

Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.

Dr. Trevor Bedford described the newly emerged Lambda variant.

Dr. Larry Corey shared his reflections on the COVID vaccine program.

Dr. Joe Unger discussed efforts to measure whether changes to clinical trials during the pandemic affected data quality.

Kelly O’Brien shared that Fred Hutch received its first cryptocurrency philanthropic gift. 

Dr. Roberty Bradley discussed a new study that is using experimental compounds that alter RNA to boost the effectiveness of immunotherapy drugs against cancer cells.

Dr. Stephaun Wallace and co-authors wrote an op-ed on the misperceptions around vaccine hesitancy.

Dr. Jesse Bloom’s preprint on recovered sequences of early SARS-CoV-2 cases was featured. 

Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.

Dr. Stephaun Wallace explained why people who previously had COVID-19 still need to get vaccinated. 

Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”

Dr. Steve Henikoff commented on a “landmark” study that adds greater detail of the genome. He said it will enable other research questions, including “What happens in cancer?” and “What happens if you compare offspring to parents?”

In Seattle Gay News’ inaugural podcast, Dr. Stephaun Wallace discussed COVID and HIV vaccine research and engaging communities in science. He said, “One of the things I really appreciate about science is that you’re always learning something.”

Dr. Trevor Bedford reacted to speculation that a clade of the influenza virus may have gone extinct during the pandemic. He said, “I think it has a decent chance that it’s gone. But the world’s a big place.”

Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”

Dr. Ruth Etzioni characterized how she thinks about the true COVID death toll.

Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.

Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."

Drs. Stan Riddell and Shivani Srivastava described research in cell therapies for solid tumors. She said, “All the reasons that make it technically complex are also the reasons why the insights you get are...more likely to be clinically relevant.”

Dr. Jesse Bloom commented on how the 1918 flu virus evolved to become more deadly.

Dr. Rachel Issaka gave insights on the new guidelines for colonoscopies. 

Dr. Michele Andrasik commented on building vaccine confidence.

Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”

Kelly O’Brien shares how a local milk company is raising money for cancer research. 

Dr. Jesse Bloom commented on a Science letter he wrote with 17 other scientists.

Dr. Josh Schiffer stressed rapid vaccination.

Dr. Chris Li shared results from his study of bisphosphonates and breast cancer.

Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.

Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.

Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.

In a profile, Dr. Leah Schmidt talked about her research in Dr. Phil Greenberg’s lab to develop T-cell therapy for lung cancer.

Dr. Rachel Issaka critiqued a study’s consent process.

Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.

Drs. Melody Campbell and Barry Stoddard described the newly-opened cryoEM facility.

Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.

Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.

Dr. Stephaun Wallace reflected on his career in public health.

Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:

Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.

Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.

Dr. Jesse Bloom discussed COVID mutations with Bloomberg. 

Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.

Allison Greaney of Dr. Jesse Bloom’s lab discussed SARS-CoV-2 virus mutations.

In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.

Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.

Dr. Trevor Bedford commented on advances in the viral genomics field.

Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.

GeekWire covered Fred Hutch’s Science Says virtual event where Hutch scientists discussed their latest work.

Dr. Joe Unger explained his study showing that in cancer patients, “access to guideline-based care...alone is not sufficient to eliminate disparate outcomes related to socioeconomic deprivation.”

Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.

In a Q&A, Dr. Josh Hill discussed treating infections in people receiving CAR T-cell therapy.

Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.

Dr. Josh Schiffer discussed his computational modeling of COVID-19 and a potential fourth wave of infections.

Dr. Laura Matrajt discussed her mathematical models of COVID-19 vaccine distribution.

STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.

Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.

Dr. Mark Roth discussed his research on suspended animation and how it’s inspired by people who survive near-death experiences.

Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..

Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.

Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.

Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.

Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.

Dr. Tyler Starr discussed how viruses like SARS-CoV-2 evolve and spread through populations of people.

Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.

Dr. Stephanie Lee discussed how cancer treatment can be adjusted due to the pandemic.

Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.

Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.

Dr. Stephanie Lee discussed new clinical trial results.

A new company called Ensoma launched based on research from Dr. Hans-Peter Kiem’s lab. The company is developing gene editing treatments, gene therapies and gene regulators.

In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.

Drs. Jesse Bloom and Tyler Starr are highlighted in The National Institutes of Health's Director's Blog about which coronavirus variants will resist antibody treatment.

Dr. David Maloney commented on the FDA approval of a CAR T-cell therapy developed in part at Fred Hutch.

Dr. Heather Greenlee described her goal for the Cook for Your Life website.

Dr. Rachel Bender Ignacio stressed the need for treatments as COVID-19 likely becomes endemic.

Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa. 

Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.

Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.

Dr. Josh Schiffer shared his prediction of what the next wave of the coronavirus pandemic could look like.

Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.

Dr. Tyler Starr discussed his research on predicting possible mutations to SARS-CoV-2, including one that is now part of the variant called B.1.1.7.

Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.

Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.

Dr. Larry Corey discussed the global significance of the upcoming Janssen vaccine trial results.

Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”

Dr. Stephaun Wallace explained how mobile sites can increase vaccination rates among communities of color.

The story quoted tweets from Dr. Trevor Bedford, in which he noted that “The fact that we’ve observed three variants of concern emerge since September suggests that there are likely more to come.”

Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.

Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”

Dr. Thomas Lynch described the gratification of improving lung cancer death rates in the US.  

Dr. Trevor Bedford explained that the lack of flu virus genomes will make it difficult to select strains for next season’s flu vaccine.

Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.

Dr. Larry Corey discussed why COVID vaccine Phase 3 trials focused on finding out if the vaccines reduced severe disease and didn’t measure transmission.

Dr. Larry Corey commented on the limited data about whether COVID vaccines prevent transmission.

Dr. Rachel Issaka described how patients should approach at-home colon cancer tests with their doctors.

Dr. Laura Matrajt discussed her computer model that showed the benefit of administering one-dose vaccines to end the pandemic.

Dr. Jesse Bloom discussed his latest paper about coronavirus mutations and their implications for vaccine efficacy.

Dr. Trevor Bedford predicted the SARS-CoV-2 variant of concern “to go from initial arrivals in the U.S. in December to starting to kind of dominate the virus population in, say, March.”

Kathy Alexion shared some of her top priorities for 2021 as Fred Hutch’s Chief Information Officer

Allison Greaney of Dr. Jesse Bloom’s lab described their study of 4,000 SARS-CoV-2 mutations.

Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.

Infectious disease reporter Helen Branswell recalled an interview with Dr. Trevor Bedoford about SARS-CoV-2 in early 2020.

Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors. 

Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.

GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.

FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.

KING 5 highlighted a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.

Time included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.

KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.

GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.

Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies. 

 Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.

FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.

KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.  

GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.  

OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer. 

Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.

Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.

Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study. 

HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for 

Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.

HealthDay highlights Dr. Bernardo Goulart’s work on the impact of high out-pocket costs on the survival of lung cancer patients with certain mutations.  

Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.

FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.

The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates. 

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required. 

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates. 

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.

Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production. 

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.  

Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.  

GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system. 

The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.

The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells. 

GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data. 

The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board. 

The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.

The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.

Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk. 

Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.

Ecancer, April 15, 2019

At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.

Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. Dr. Wright is currently conducting a trial on overweight patients with low-grade, slow growing prostate cancer to see if monitoring their glucose levels through a weight loss period will improve their cancer outcomes.

NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.

In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.

Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.

KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle. 

Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.

CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.

Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."

Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community. 

Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV. 

Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.

KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.

Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”

In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.

Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research. 

This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.

Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.

This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.

This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy. 

This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV). 

This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.

Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”

This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers. 

Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus. 

Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy. 

GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.

This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV. 

Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016. 

Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer. 

This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study. 

Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column. 

Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.

Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research. 

Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer. 

Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%. 

This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency. 

Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity

This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study. 

This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study. 

This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive. 

Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.

Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.

Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells. 

This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.

This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later. 

Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch. 
 

Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today. 

This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year. 

Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants. 

Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.

Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.

Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.

Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.

Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.

This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.

Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.

Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.

This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.

This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.

Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.

This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.

This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.

This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required

Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.

Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.

This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.

Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.

Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.

This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.

Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.

Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."

Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.

Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.

This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.

Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.

This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.

KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.

GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.

Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.

Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.

Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.

Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.

Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.

This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.

This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.

This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.

Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.

In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.

Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.

Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors

This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.

Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.

KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.

This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.

In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.

Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.

Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.

Jean Nelson, a top-10 “Base 2 Space” stair-climber in last year’s event, is among those who got to climb to the top of the Space Needle mast. “Base 2 Space” participants ascend the 832 stairs of Seattle’s landmark, and the latest event raised more than $860,000 for Fred Hutch research.

This story profiles the experience of two high school science teachers, participating in Fred Hutch’s Science Education Partnership. The program pairs science teachers with Fred Hutch researchers to gain skills and expertise to bring into the classroom.

Fred Hutch researchers are working with the city of Seattle to investigate whether firefighters at Station 31 have higher cancer rates than those at other stations. Designed to answer longstanding questions, the study is expected to conclude by summer 2019.

Dr. Amanda Phipps provided comment in this story, examining the links of sleep and cancer. Phipps notes “from a biological perspective, there are a lot of good reasons for us to suspect that insufficient sleep, chronic sleep debt or short sleep duration could have an impact on the development of cancer."

Fred Hutch researchers led by Dr. Matthias Stephan used nanoparticles to deliver two drugs directly into solid tumors to shut down the tumors’ defense mechanisms and rally the immune system. Although this was a preclinical study, not done in human patients, it opens the possibility that chimeric antigen receptor (CAR) T-cell therapies could be used not just in blood cancers but also in solid tumors. The drugs would precondition the patient and the tumor so the T cells would work better, Stephan said.

This article published by Managed Care, focuses on the “Community Cancer Care in Washington State: Quality and Cost Report” recently released by the Hutch’s health care economics group, HICOR. “Committing to transparency as a catalyst for improvement, 27 hospital systems and cancer centers across Washington State bare all in the first public report to integrate clinic-level quality and cost data in oncology,” the article said.

Drs. Jeffrey Schouten and Thomas Uldrick were interviewed for a cover story on HIV and cancer for Healio’s HemOnc Today. “How to prevent cancer in people with HIV and oncogenic viral infections, and how to diagnose the resultant cancers early so that treatment outcomes are improved, are important issues that need to be addressed for patients,” Schouten said.

Fred Hutch physician-scientist Dr. Eric Holland, senior vice president and director of the Human Biology Division, led a study that found that a subset of brain cancers called ependymomas can be traced back to a single, catastrophic mutation in a patient’s DNA. “It looks like a region of the DNA blew up,” he said. The GeekWire story also was reported on KIRO-TV.

Jane Ann Morrison, a columnist with the Las Vegas Review-Journal, told readers that her 88-year-old father, Jim Morrison, a retired Boeing engineer who was diagnosed with non-Hodgkin lymphoma in 1991, was honored as a Hutch Hero at a June 14 Seattle Mariners game. “His bone marrow transplant at the center in 1993 has given my dad 25 additional years (and I predict even more),” she said.

The U.K. newspaper Daily Mail, Yahoo! UK, ABC News Australia and other sites carried an article about Fred Hutch research published in the American Journal of Obstetrics and Gynecology suggesting that red meat intake increases estrogen levels, which can lead to endometriosis.

Four days after the Hutch’s lease of the historic Lake Union steam plant was announced, real estate developer William Justen recounted the deal’s three-decade history.

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

New Fred Hutch Board of Trustees chair Matt McIlwain and Fred Hutch COO Steve Stadum talk about the intersection of cancer research and technology. The story also notes the new additions of board members Allan Jones, president and CEO of the Allen Institute, and Lyft CFO Brian Roberts, a former high-ranking Microsoft executive.

“The HIV epidemic is global and our research works to make sure our solutions reach those most vulnerable,” said Steven Wakefield, president of the Pride Foundation in a feature profile. Wakefield is external relations director for the HIV Vaccine Trial Network that is headquartered at the Hutch, where he established The Legacy Project to increase racial and ethnic involvement in clinical trials.

Dr. Seth M. Pollack, a sarcoma expert at Fred Hutch, talks about the potential for – and the challenges in – creating vaccines to treat and prevent cancer. “There almost certainly is not a universal target. The vaccine has to tell the immune system to go find something specific, but there’s nothing specific that the immune system can look for that is common to all cancers,” he said, adding that “there are some targets that are expressed by lots of cancers.”

Dr. Jennifer Specht, a Fred Hutch breast cancer researcher, appeared live on KING 5's "Take Five" news show to provide expert commentary on a new breast cancer treatment study.

Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.

Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.

Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.

Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla. 

Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.

KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.

In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.

Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.

Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.

A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”

Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.

Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.

The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.

Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.